BVF »

Research Alliance Corp Iii shares owned by BVF

Quarter-by-quarter ownership of Research Alliance Corp Iii shares owned by BVF from 13F filings

Historical chart of BVF investment in Research Alliance Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Research Alliance Corp Iii held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Research Alliance Corp Iii by BVF

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.4M 500k 10.70

More positions owned by BVF

Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Xoma Royalty Corporation Com New (XOMA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Gh Research Ordinary Shares (GHRS)
Structure Therapeutics Sponsored Ads (GPCR)
Nektar Therapeutics Com New (NKTR)
Mirum Pharmaceuticals (MIRM)
Xencor (XNCR)
Alkermes SHS (ALKS)
Monte Rosa Therapeutics (GLUE)
Cullinan Oncology (CGEM)
Palvella Therapeutics Inc Ne (PVLA)
Zymeworks Del (ZYME)
Kura Oncology (KURA)

View all positions for BVF

Top funds holding Research Alliance Corp Iii

Perceptive Advisors
ADAR1 Capital Management
BVF
Balyasny Asset Management
Spruce Street Capital
Trails Edge Capital Partners
TCG Crossover Management
Commodore Capital
Jupiter Topco
Braidwell
Cormorant Asset Management
Affinity Asset Advisors
Silverarc Capital Management
VR Adviser
J. Goldman & Co

View all funds holding Research Alliance Corp Iii